This template does not require a rating on Wikipedia'scontent assessment scale. It is of interest to the followingWikiProjects:

Pharmacology This template is within the scope ofWikiProject Pharmacology, a collaborative effort to improve the coverage ofPharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can jointhe discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology Chemicals This template is within the scope ofWikiProject Chemicals, a daughter project ofWikiProject Chemistry, which aims to improve Wikipedia's coverage ofchemicals. To participate, help improve this template or visit theproject page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals Medicine This template is within the scope ofWikiProject Medicine. Please visit the project page for details or ask questions atWikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine Molecular Biology:MCB This template is within the scope ofWikiProject Molecular Biology, a collaborative effort to improve the coverage ofmolecular biology on Wikipedia. If you would like to participate, please visit the project page, where you can jointhe discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology This template is supported bythe Molecular and Cell Biology task force.

One in-vitro study determined that ibuprofen at 500μM induced lipogenesis, the main hallmark of PPARγ activation, 100μM had no effect; 500μM translates to an oral dose in the ballpark of 3,100mg—is this effect relevant enough to include in this template?

Indomethacin with 80μM as the lipogenic dose translates to doses far exceeding 1,000mg—another super-therapeutic dose.

In that study, the method for determining agonist efficacy is questionable—it does not assess PPARγ with its RXRα coactivator, hence ibuprofen could in fact be a weak partial agonist when paired with RXRα—which is why I'm ignoring it.

Pleased to hear additional information, but at this point I'm very tempted to remove this potentially misinformed item.Insect.eate (talk)00:35, 10 October 2024 (UTC)[reply]

Correction: Ibuprofen is sometimes administered in doses of 800mg 4 times daily, quite possibly enough for PPARγ effects to manifest. I don't know what to do here, input from others is appreciated—I'm not sure whether items in templates are supposed to be clinically relevant examples, or whether tentative in-vitro evidence is enough for inclusion.

If it's the latter, NSAIDs like indomethacin and naproxen should possibly be included alongside ibuprofen.Insect.eate (talk)05:44, 12 October 2024 (UTC)[reply]

• Template-Class pharmacology pages
• NA-importance pharmacology pages
• WikiProject Pharmacology articles
• Template-Class chemicals pages
• NA-importance chemicals pages
• Template-Class medicine pages
• NA-importance medicine pages
• All WikiProject Medicine pages
• Template-Class Molecular Biology pages
• NA-importance Molecular Biology pages
• Template-Class MCB pages
• NA-importance MCB pages
• WikiProject Molecular and Cellular Biology articles
• All WikiProject Molecular Biology pages